Tesamorelin 10mg – Research-Grade Peptide
This product, Tesamorelin 10mg, is specifically intended for research purposes and not for human or animal consumption. It serves as a growth hormone-releasing hormone (GHRH) analog with applications in various biological studies.
Research Context
Tesamorelin was developed by Amgen Inc., originally as a potential treatment for muscle wasting conditions, including HIV-associated lipodystrophy and weight loss. It functions through mimicking the effects of GHRH to stimulate growth hormone production and release in the body.
Research Overview
This research-grade peptide is widely used in scientific investigations due to its ability to modulate growth hormone levels, making it a valuable tool for studying the physiological mechanisms underlying growth hormone secretion. It also has applications in understanding processes related to aging, metabolism, and muscle physiology.
Key Research Focus Areas
- Biochemical Studies: Assays aimed at characterizing the activity of GHRH analogs and their effects on growth hormone release.
- Toxicology: Evaluating potential side effects or toxicological profiles in various cell lines to understand safety parameters.
- Molecular Biology: Investigating gene expression patterns and protein interactions associated with growth hormone regulation pathways.
- Pharmacokinetics: Studying the absorption, distribution, metabolism, and excretion of Tesamorelin in vitro or ex vivo models to elucidate its pharmacological properties.
Compliance Disclaimer
Please note that this product is for research use only. Not for human or animal consumption.
| Size | 10MG |
|---|
Reviews
There are no reviews yet.